35 percent of patients with breast cancer worried about genetic risks to themselves, family members
the ONA take:
According to a new study conducted at the University of Michigan Comprehensive Cancer Center in Ann Arbor, Michigan, researchers have found that a third of women diagnosed with breast cancer are concerned about the genetic risk of a family member developing cancer or developing other cancers themselves.
For the study, researchers surveyed 1,536 women who had been treated for breast cancer that were included in the Surveillance, Epidemiology and End Results (SEER) databases.
Results showed that 35% of women with breast cancer expressed a strong desire for genetic testing, while 43% did not have a discussion about genetic testing with a health care professional.
The study also found that racial minority participants were less likely than white patients to discuss genetic testing with a health care professional despite a strong desire to do so.
Researchers found that many patients, particularly Latinas who spoke only Spanish, were concerned that their loved ones might get breast cancer in the future due to inherited risk.
Study results were published in the Journal of Clinical Oncology.
A third of women diagnosed with breast cancer are concerned about the genetic risk of a family member developing cancer.
Sign Up for Free e-newsletters
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Identifying the Psychosocial Needs of Young Adults With Metastatic Cancer
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- Partial Response Achieved With Atezolizumab, Cobimetinib in Pretreated CRC
- Novel Approach Can Improve Both Colorectal Cancer Screening Outcomes and Adherence
- Survival Outcomes in Relapsed Hepatocellular Carcinoma Improved With Cabozantinib
- OS Similar With Gemcitabine Plus S-1 vs Standard Therapy for Biliary Tract Cancer
- Feasibility and Outcomes of Modified Enhanced Recovery After Surgery for Nursing Management of Aged Patients Undergoing Esophagectomy
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|